A HER2 Tri-Specific NK Cell Engager Mediates Efficient Targeting of Human Ovarian Cancer

SIMPLE SUMMARY: HER2 is a marker known to be over-expressed on breast cancer, rendering it one of the most useful solid tumor targets for antibody-based therapies. Despite expression on ovarian cancer, results targeting HER2 in this setting have been disappointing, thus requiring more aggressive app...

Descripción completa

Detalles Bibliográficos
Autores principales: Vallera, Daniel A., Oh, Felix, Kodal, Behiye, Hinderlie, Peter, Geller, Melissa A., Miller, Jeffrey S., Felices, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394622/
https://www.ncbi.nlm.nih.gov/pubmed/34439149
http://dx.doi.org/10.3390/cancers13163994

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394622/
https://www.ncbi.nlm.nih.gov/pubmed/34439149
http://dx.doi.org/10.3390/cancers13163994

Ejemplares similares